The 5.5 mL syringe is currently in development with samples for feasibility studies expected to be available in mid-2026. Within the same timeframe, Ypsomed plans to expand the YpsoMate 5.5 platform ...
SRMs were obtained from NIST for technetium 99m, indium 111, thallium 201, and iodine 131. These materials were received in aqueous solutions with an approximate volume of 5 mL, each contained in a ...
In a safety alert issued August 18, the FDA said compounded or repackaged drugs that have been stored in 3- and 5-mL syringes manufactured by Becton-Dickinson should not be administered to patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results